Advertisement
MTX vs TMDX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTX is a Buy and TMDX is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MTX’s FA Score shows that 0 FA rating(s) are green whileTMDX’s FA Score has 0 green FA rating(s).
- MTX’s FA Score: 0 green, 5 red.
- TMDX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MTX’s TA Score shows that 4 TA indicator(s) are bullish while TMDX’s TA Score has 4 bullish TA indicator(s).
- MTX’s TA Score: 4 bullish, 5 bearish.
- TMDX’s TA Score: 4 bullish, 5 bearish.
Price Growth
MTX (@Chemicals: Specialty) experienced а +4.24% price change this week, while TMDX (@Medical Specialties) price change was +6.38% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +1.67%. For the same industry, the average monthly price growth was +3.48%, and the average quarterly price growth was +2.10%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was -0.23%.
Reported Earning Dates
MTX is expected to report earnings on Jul 24, 2025.
TMDX is expected to report earnings on Jul 31, 2025.
Industries' Descriptions
@Chemicals: Specialty (+1.67% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
@Medical Specialties (+1.08% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| MTX | TMDX | MTX / TMDX | |
| Capitalization | 2.4B | 2.4B | 100% |
| EBITDA | 262M | -7.7M | -3,401% |
| Gain YTD | -26.914 | 110.810 | -24% |
| P/E Ratio | 28.70 | N/A | - |
| Revenue | 2.17B | 242M | 897% |
| Total Cash | 322M | 395M | 82% |
| Total Debt | 1.01B | 516M | 197% |
MTX | TMDX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 53 | 68 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 84 Overvalued | |
PROFIT vs RISK RATING 1..100 | 82 | 42 | |
SMR RATING 1..100 | 90 | 41 | |
PRICE GROWTH RATING 1..100 | 85 | 37 | |
P/E GROWTH RATING 1..100 | 98 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MTX's Valuation (66) in the Industrial Specialties industry is in the same range as TMDX (84) in the Medical Specialties industry. This means that MTX’s stock grew similarly to TMDX’s over the last 12 months.
TMDX's Profit vs Risk Rating (42) in the Medical Specialties industry is somewhat better than the same rating for MTX (82) in the Industrial Specialties industry. This means that TMDX’s stock grew somewhat faster than MTX’s over the last 12 months.
TMDX's SMR Rating (41) in the Medical Specialties industry is somewhat better than the same rating for MTX (90) in the Industrial Specialties industry. This means that TMDX’s stock grew somewhat faster than MTX’s over the last 12 months.
TMDX's Price Growth Rating (37) in the Medical Specialties industry is somewhat better than the same rating for MTX (85) in the Industrial Specialties industry. This means that TMDX’s stock grew somewhat faster than MTX’s over the last 12 months.
MTX's P/E Growth Rating (98) in the Industrial Specialties industry is in the same range as TMDX (100) in the Medical Specialties industry. This means that MTX’s stock grew similarly to TMDX’s over the last 12 months.
| MTX | TMDX | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 73% |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 80% |
| Momentum ODDS (%) | 2 days ago 61% | 2 days ago 81% |
| MACD ODDS (%) | 2 days ago 52% | 2 days ago 78% |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 88% |
| TrendMonth ODDS (%) | 2 days ago 62% | 2 days ago 89% |
| Advances ODDS (%) | 4 days ago 64% | 4 days ago 86% |
| Declines ODDS (%) | 8 days ago 65% | 8 days ago 81% |
| BollingerBands ODDS (%) | 2 days ago 60% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 64% | 2 days ago 89% |
Advertisement
MTX and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTX has been loosely correlated with RPM. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if MTX jumps, then RPM could also see price increases.
| Ticker / NAME | Correlation To MTX | 1D Price Change % | ||
|---|---|---|---|---|
| MTX | 100% | -0.18% | ||
| RPM - MTX | 66% Loosely correlated | +1.03% | ||
| FUL - MTX | 64% Loosely correlated | +10.31% | ||
| AVNT - MTX | 64% Loosely correlated | -0.64% | ||
| OLN - MTX | 64% Loosely correlated | +1.04% | ||
| IOSP - MTX | 62% Loosely correlated | -0.11% | ||
More | ||||
TMDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with RDNT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then RDNT could also see price increases.
| Ticker / NAME | Correlation To TMDX | 1D Price Change % | ||
|---|---|---|---|---|
| TMDX | 100% | +1.06% | ||
| RDNT - TMDX | 36% Loosely correlated | -1.57% | ||
| ALGN - TMDX | 33% Poorly correlated | +0.43% | ||
| SMTI - TMDX | 32% Poorly correlated | +0.18% | ||
| NVST - TMDX | 32% Poorly correlated | +0.10% | ||
| GKOS - TMDX | 32% Poorly correlated | +0.36% | ||
More | ||||